In today’s The Straits Times, our Medical Director, Dr Lim Zi Yi, reflects on two patients with multiple myeloma whom he treated many years apart.
Their stories began in remarkably similar ways, but advances in targeted treatments, stem cell transplantation and immune-based therapies meant that their journeys were very different.
Myeloma remains a serious and currently incurable blood cancer. However, treatment today can often provide longer periods of disease control, better quality of life and further options when the disease returns.
As Dr Lim writes, the progress is not measured only in statistics, but in something deeply meaningful: more time with family, more time to make plans and more time to continue living.
Read the full article in The Straits Times:
